Seeking Alpha

HALO

Halozyme Therapeutics, Inc.

5/24/2012, 1:57 AM ET

Business Intelligence
Transcripts
Events
Key Developments

52wk high:

52wk low:

EPS:

PE:

Div Rate:

Yield:

Market Cap:

Volume:

293 people get HALO articles and Market Currents by email alert.

Get email alerts on HALO »

HALO Market Currents more »

May 7 Halozyme Therapeutics (HALO): Q1 EPS of $0.14 beats by $0.25. Revenue of $7.4M (-1.3% Y/Y) in-line. (PR)
Comment!
[Earnings, Healthcare]

HALO in Focus more »

A Halo Comes Off

InsiderInsights • Mon, Apr 30 • 3 Comments
A Very Compelling Biopharmaceutical Investment

Steven Bulwa • Wed, Apr 18 • 6 Comments
Halozyme's New High

Jessica King Holden • Wed, Feb 1 • 1 Comment
Widespread Potential For Halozyme

Jessica King Holden • Tue, Jan 17 • Comment!
Halozyme Gets Good News From Roche's Subcutaneous Herceptin Phase 3 Trial

M. E. Garza • Wed, Oct 19, 2011 • Comment!

HALO Related Articles more »

Insider Buys And Sells: Netflix Buys And NVR Sales

Asif Suria • Sun, May 20 • 2 Comments
Insider Buying Trends: Are These Cash-Rich Companies Ready For A Rally?

Kapitall • Sun, May 20 • Comment!
Noteworthy Insider Buys Last Week In 2 Beaten Down Biotechs, With 4 Other Buys And Sells

Ganaxi Small Cap Movers • Sat, May 19 • 2 Comments
Top Insider Trades On May 17: Buying At Hess And Halozyme

InsiderInsights • Fri, May 18 • 1 Comment
Baxter Still Defensive, But Is Now The Time For Offense?

Stephen Simpson • Tue, May 15 • Comment!
Mid Cap Biotech Stocks Being Accumulated By The World's Largest Money Managers

Ganaxi Small Cap Movers • Tue, Apr 17 • 1 Comment
Top Small-Cap Biotech Stocks Being Accumulated By Legendary Fund Managers

Ganaxi Small Cap Movers • Tue, Apr 17 • 6 Comments
Reading Into Prolor's Technology Offering: Major Partnership On The Horizon

Timeless Wealth • Mon, Apr 16 • Comment!
Biodel Back At Square One, Not Zero

Stephen Simpson • Thu, Apr 12 • 1 Comment
4 Biotech Stocks With Strong Upside Potential

Ry Frank • Tue, Mar 27 • 7 Comments

HALO News more »

Lightning Round: ConocoPhillips, MeadWestvaco, Yandex and More

at CNBC.com (Jan 18, 2012)
Biotech Stocks: Drug stocks slump with broader market

at MarketWatch.com (May 7, 2010)

HALO Press Releases and Filings more »

Halozyme Therapeutics to Present at the Bank of America Merrill Lynch 2012 Health Care Conference

PR Newswire (May 9, 2012)
Halozyme Reports First Quarter 2012 Financial Results

PR Newswire (May 7, 2012)
Halozyme to Host First Quarter 2012 Financial Results Conference Call

PR Newswire (Apr 30, 2012)
Baxter and Halozyme Provide Update on HyQ Biologics License Application

PR Newswire (Apr 16, 2012)
Halozyme Therapeutics to Present at the Oppenheimer Annual Healthcare Conference on December 13

PR Newswire (Dec 7, 2011)

HALO Latest Transcript more »

Halozyme Therapeutics, Inc. Q3 2009 Earnings Call Transcript

Fri, Nov 6, 2009
Popular searches: greg, halozyme, roche, biotech, study, GAMMAGARD, baxter, csl.

Earlier HALO transcripts

HALO Cramer more »

Cramer's Lightning Round - You Must Own MeadWestvaco (1/18/12)

Thu, Jan 19

HALO Instablog posts more »

Halozyme Therapeutics, Inc. (HALO) Announces Completion of Enrollment of Phase III Study

Wed, Dec 8, 2010 • QualityStocks • Comment!
Cancer Catalyst Calendar Updated => Rx Investors.com

Tue, Nov 9, 2010 • Justin M. Hall • Comment!
A Simple Screen to Beat the Market

Sat, Oct 23, 2010 • Brian Burns • Comment!
RXI's NEW Cancer Catalyst Calendar ==> Rx Investors.com

Sun, Oct 17, 2010 • Justin M. Hall • Comment!
Biotech Events: June Medical and Investor Conferences (Jefferies List)

Fri, Jun 4, 2010 • Andrew Nava • Comment!

Write a post on HALO

HALO StockTalks

HALO vs. ETF Alternatives

Company Description

Currently, there's no company description for HALO.

Sector: Healthcare

Industry: Biotechnology

Country: United States